New Wave Biotech
London · Founded 2022
About New Wave Biotech
New Wave Biotech develops downstream process optimization software to help alternative protein and other synthetic biology products get to market quicker, cheaper, and more sustainable. Using computational modeling and AI, their software conducts virtual experiments on billions of potential processes and learns from experimental data to provide recommendations for optimization, helping biomanufacturers accelerate R&D and reduce production costs.
Company Facts
- Founded: 2022
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.4M
- Funding stage: Seed
- Last round: Grant (Oct 2025)
- Website: https://www.newwavebiotech.com/
- Phone: [email protected]
Industries & Categories
Advanced Materials, Alternative Protein, Biotechnology, Machine Learning, SaaS
Social Profiles
Canonical: https://fsome.com/organization/new-wave-biotech-59494 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.